Classic NEPC subtype do not express AR and thus do not respond to ADT These “aggressive” prostate cancers rarely arise “de novo”, and most often appear after ADT, at a frequency of 10 to 20% [301]. This evidence concerns the gene AR and prostate carcinoma.